TITLE

Novel punctal plug approach to glaucoma drug delivery well-tolerated, lowers IOP

AUTHOR(S)
Gedde, Stephen
PUB. DATE
December 2008
SOURCE
Ocular Surgery News Europe/Asia-Pacific Edition;Dec2008, Vol. 19 Issue 12, p13
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses findings of research on the novel punctual plug approach to glaucoma drug delivery, as presented by Richard A. Lewis at the 2008 American Academy of Ophthalmology meeting. A pilot study by Lewis and colleagues showed the device was well-tolerated and had no side effects. However, the retention rate using a commercial plug was not optimal, according to Lewis. Preliminary results of the second phase of the study revealed a statistically significant drop in mean IOP from baseline.
ACCESSION #
35376207

 

Related Articles

  • Novel punctal plug approach to glaucoma drug delivery well-tolerated, lowers IOP.  // Ocular Surgery News;12/10/2008, Vol. 26 Issue 23, p18 

    The article discusses the highlights of the American Academy of Ophthalmology meeting that was held in Atlanta, Georgia from November 8 to 11, 2008. Ophthalmologist Richard A. Lewis discussed a novel punctal plug approach to glaucoma drug delivery. He described a study that he and his colleagues...

  • Glaucoma, non-glaucoma patients who underwent DSEK had similar high IOP, visual outcomes. Sarkisian Jr., Steven R. // Ocular Surgery News Europe/Asia-Pacific Edition;Dec2008, Vol. 19 Issue 12, p12 

    The article discusses results of a study on visual acuity for glaucoma and non-glaucoma patients after Descemet's stripping endothelial keratoplasty (DSEK), as presented by Thasarat S. Vajaranant at the 2008 American Academy of Ophthalmology meeting. Vajaranant and colleagues found that the...

  • Speakers celebrate 100 years of progress. Gordon, Richard N. // Ophthalmology Times;04/01/97, Vol. 22 Issue 7, p6 

    Reports on the topics discussed at the third day of the 1996 Annual Meeting of the American Academy of Ophthalmologists in Chicago. Review of olden glaucoma understanding; Study of aqueous humor outflow and interruptions; Peter's and Reiger's anomaly genetic findings; Glaucoma filtration...

  • `Glaucoma at the Millennium' topics explored. Costa, Vital P. // Ophthalmology Times;02/15/97, Vol. 22 Issue 4, p5 

    Highlights some of the presentations at the `Glaucoma at the Millennium' session featured at the 1996 meeting of the American Academy of Ophthalmology. Correlation between the Heidelberg Retinal Tomograph and visual field examinations; Psychophysical tests in primary open-angle and...

  • Go ahead--make a difference. Malley, Mike // Ophthalmology Times;1/16/95, Vol. 20 Issue 3, p3 

    Comments on the promotion of the American Academy of Ophthalmology (AAO) of a glaucoma diagnosis program during the National Glaucoma Awareness Week. Focus of the program on reducing the risk of blindness; Significance of glaucoma screening; Involvement of ophthalmologists in eliminating...

  • AAO: Courses easier to navigate. Hertz, Beth Thomas // Ophthalmology Times;10/1/2011, Vol. 36 Issue 19, p12 

    The article offers information on the American Academy of Ophthalmology (AAO) meeting to be held in Orlando, Florida on October 22-25, 2011.

  • Normal tension glaucoma cases require unique treatment methods.  // Ocular Surgery News Europe/Asia-Pacific Edition;Dec2008, Vol. 19 Issue 12, p16 

    The article suggests that preventing glaucomatous progression in normal tension glaucoma patients necessitates different treatment regimens than primary open-angle glaucoma. Speaking at the 2008 American Academy of Ophthalmology meeting, Kuldev Singh admitted he more often follows untreated...

  • Anti-VEGF shows good results in treating DME at 12 months. Campochiaro, Peter A. // Ocular Surgery News Europe/Asia-Pacific Edition;Dec2008, Vol. 19 Issue 12, p12 

    The article reports on the effectiveness of ranibizumab for the treatment of diabetic macular edema, according to a presentation by Pascale G. Massin at the 2008 American Academy of Ophthalmology meeting. Efficacy in ranibizumab-treated patients during the phase 2 RESOLVE study showed clinical...

  • Study of giant cell arteritis rates largest ever conducted in U.S., researcher says.  // Ocular Surgery News Europe/Asia-Pacific Edition;Dec2008, Vol. 19 Issue 12, p15 

    The article claims that a study of temporal artery biopsies performed in Northern California had the largest and most diverse patient population of any similar study in the U.S. Speaking at the 2008 American Academy of Ophthalmology meeting, Matthew Walvick suggested that the study showed a much...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics